Evidence map›Paper›PMID 38952279›Full record

ArticleRenal failure2024

Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease.

Qing Yang, Yutong Zou, Yanlin Lang, Jia Yang, Yucheng Wu, Xiang Xiao, Chunmei Qin, Yuancheng Zhao, Fang Liu

Abstract read
In one paragraph

Article in Renal failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qing YangDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Yutong ZouDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Yanlin LangDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Jia YangDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Yucheng WuDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Xiang XiaoDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.ORCID 0000-0002-9714-9543
Chunmei QinDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Yuancheng ZhaoDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Fang LiuDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, China.ORCID 0000-0003-1121-3004

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study aimed to investigate the correlations between estimated small dense low-density lipoprotein-cholesterol (esd-LDL-c) and the development of end-stage kidney disease (ESKD), cardiovascular mortality, and all-cause mortality in individuals with diabetic kidney disease (DKD) or diabetes mellitus (DM) concomitant chronic kidney disease (CKD).

methodsWe analyzed the data from a biopsy-proven DKD cohort conducted at West China Hospital of Sichuan University between 2009 and 2021 (the DKD cohort) and participants with DM and CKD in the National Health and Nutrition Examination Survey (NHANES) 2011-2014 (the NHANES DM-CKD cohort). Cox regression analysis was also used to estimate associations between esd-LDL-c and the incidence of ESKD, cardiovascular mortality, and all-cause mortality.

resultsThere were 175 ESKD events among 338 participants in the DKD cohort. Patients were divided into three groups based on esd-LDL-c tertiles (T1 < 33.7 mg/dL, T2 ≥ 33.7 mg/dL to <45.9 mg/dL, T3 ≥ 45.9 mg/dL). The highest tertile of esd-LDL-c was associated with ESKD (adjusted HR 2.016, 95% CI 1.144-3.554,

conclusionsHigher esd-LDL-c was associated with increased risk of ESKD in people with biopsy-proven DKD, and higher cardiovascular and all-cause mortality risk among those with DM-CKD.

Indexed as

Cardiovascular DiseasesCholesterol, LDLDiabetic NephropathiesKidney Failure, ChronicAdultAgedChinaFemaleHumansIncidenceMaleMiddle AgedNutrition SurveysRenal Insufficiency, ChronicRisk FactorsCholesterol, LDLcohort studydiabetic kidney diseaserisk factorsmall dense low-density lipoprotein-cholesterolType 2 diabetes mellitus

Identifiers

PMID38952279
PMCPMC467091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.